Abdulmaged M. Traish, PhD

view presentation | view presentation  transcript | view abstract | watch interview video | view interview transcript | print this page

Publications 

1. Traish AM, Muller RE, Wotiz HH. Binding of estrogen receptor to uterine nuclei. Salt-extractable versus salt-resistant receptor-estrogen complexes. J Biol Chem 1977 Oct 10;252(19):6823-30.
2. Muller RE, Traish AM, Wotiz HH. Interaction of receptor-estrogen complex (R-E) with uterine nuclei. J Biol Chem 1977 Nov 25;252(22):8206-11 
3. Olsson CA, deVere White R, Goldstein I, Traish AM, Muller RE, Wotiz HHA preliminary report on the measurement of cytosolic and nuclear prostatic tissue steroid receptors. Prog Clin Biol Res 1979;33:209-21
4. Muller RE, Johnston TC, Traish AM, Wotiz HH Studies on the mechanism of estradiol uptake by rat uterine cells and on estradiol binding to uterine plasma membranes. Adv Exp Med Biol 1979;117:401-21
5. Traish AM, Muller RE, Wotiz HH Comparison of formation, activation, and nuclear translocation of receptor . estradiol (R . E2) complex at 0 degrees C and 37 degrees C in intact uterine cells. J Biol Chem 1979 Jul 25;254(14):6560-7
6. Muller RE, Traish A, Wotiz HH. Effects of pyridoxal 5'-phosphate on uterine estrogen receptor. I. Inhibition of nuclear binding in cell-free system and intact uterus. J Biol Chem 1980 May 10;255(9):4062-7
7. Traish A, Muller RE, Wotiz HH. Effects of pyridoxal 5'-phosphate on uterine estrogen receptor. II. Inhibition of estrogen receptor transformation. J. Biol Chem 1980 May 10;255(9):4068-72
8. Muller RE, Sheard BE, Traish A, Wotiz HH. Effect of chemotherapeutic agents on the formation of estrogen-receptor complex in human breast tumor cytosol. Cancer Res 1980 Aug;40(8 Pt 1):2941-2
9. Traish AM, Muller RE, Burns ME, Wotiz HH. Steroid binding proteins in rat and human prostate. Prog Clin Biol Res 1981;75A:417-34
10. Traish AM, Muller RE, Wotiz HH. A new procedure for the quantitation of nuclear and cytoplasmic androgen receptors. J Biol Chem 1981 Dec 10;256(23):12028-33
11. Muller RE, Traish AM, Beebe DA, Wotiz HH. Reversible inhibition of estrogen receptor activation by molybdate. J Biol Chem 1982 Feb 10;257(3):1295-300
12. Muller RE, Traish AM, Wotiz HH. Estrogen receptor activation precedes transformation. Effects of ionic strength, temperature, and molybdate. J Biol Chem 1983 Aug 10;258(15):9227-36
13. Muller RE, Mrabet NT, Traish AM, Wotiz HH. The role of arginyl residues in estrogen receptor activation and transformation. J Biol Chem 1983 Oct 10;258(19):11582-9
14. Muller RE, Beebe DM, Bercel E, Traish AM, Wotiz HH. Estriol and estradiol interactions with the estrogen receptor in vivo and in vitro. J Steroid Biochem 1984 Apr;20(4B):1039-46
15. Traish AM, Muller RE, Wotiz HH. Differences in the physicochemical characteristics of androgen-receptor complexes formed in vivo and in vitro. Endocrinology 1984 May;114(5):1761-9
16. Muller RE, Traish AM, Hirota T, Bercel E, Wotiz HH. Conversion of estrogen receptor from a state with low affinity for estradiol into a state of higher affinity does not require 4S to 5S dimerization. Endocrinology 1985 Jan;116(1):337-45
17. Traish AM, Muller RE, Wotiz HH. Interaction of cyproterone acetate with rat prostatic androgen receptors. Steroids 1985 Mar-Apr;45(3-4):247-62
18. Traish AM, Muller RE, Wotiz HH. Resolution of non-activated and activated androgen receptors based on differences in their hydrodynamic properties. J Steroid Biochem 1985 May;22(5):601-9
19. Traish AM, Muller RE, Wotiz HH. A new exchange procedure for the quantitation of prostatic androgen receptor complexes formed in vivo. J Steroid Biochem 1985 Oct;23(4):405-13
20. Muller RE, Traish AM, Wotiz HH. Interaction of estradiol and Estriol with uterine estrogen receptor in vivo and in excised uteri or cell suspensions at 37 C: non-cooperative estradiol binding and absence of Estriol inhibition of estradiol-induced receptor activation and transformation. Endocrinology 1985 Nov;117(5):1839-47
21. Traish AM, Muller RE, Williams DF, Wotiz HH. Changes in the sedimentation properties of cytosolic androgen receptors associated with activation in vitro and in vivo. Steroids 1985 Dec;46(6):929-46
22. Muller RE, Traish AM. The role of lysyl, arginyl, and sulfhydryl residues in estrogen receptor activation, 4S to 5S dimerization, and conversion of receptor from a state with low affinity into a state with higher affinity for estrogen. Ann N Y Acad Sci 1986;464:202-17
23. Traish AM, Williams DF, Wotiz HH. Binding of (3H)7 alpha,17 alpha-dimethyl-19-nortestosterone (mibolerone) to progesterone receptors: comparison with binding of (3H)R5020 and (3H)ORG2058.Steroids 1986 Feb-Mar;47(2-3):157-73
24. Traish AM, Muller RE, Wotiz HH. Binding of 7 alpha, 17 alpha-dimethyl-19-nortestosterone (mibolerone) to androgen and progesterone receptors in human and animal tissues. Endocrinology 1986 Apr;118(4):1327-33
25. Bronson RE, Calaman SD, Traish AM, Kagan HM Stimulation of lysyl oxidase (EC 1.4.3.13) activity by testosterone and characterization of androgen receptors in cultured calf aorta smooth-muscle cells. Biochem J 1987 Jun 1;244(2):317-23
26. Traish AM, Wotiz HH. Prostatic epidermal growth factor receptors and their regulation by androgens. Endocrinology 1987 Oct;121(4):1461-7
27. Traish AM, Williams DF, Hoffman ND, Wotiz HH Validation of the exchange assay for the measurement of androgen receptors in human and dog prostates. Prog Clin Biol Res 1988;262:145-60
28. Traish AM, Williams DF, Wotiz HH Modulation of steroid affinity for the androgen receptor by sucrose. Steroids 1989 Jan-Feb;53(1-2):169-93
29. Traish AM, Kim N, Wotiz HH Characterization of polyclonal antibodies to pre-selected domains of the human estrogen receptor. Endocrinology 1989 Jul;125(1):172-9 
30. Traish AM, Ettinger R, Kim N, Marshak-Rothstein A, Wotiz HH Development and characterization of monoclonal antibodies to a specific domain of human estrogen receptor. Steroids 1990 May;55(5):196-208
31. Traish AM, Wotiz HH Monoclonal and polyclonal antibodies to human progesterone receptor peptide-(533-547) recognize a specific site in unactivated (8S) and activated (4S) progesterone receptor and distinguish between intact and proteolyzed receptors. Endocrinology 1990 Sep;127(3):1167-75
32. Traish AM, Carson MP, Kim N, Goldstein I, Saenz de Tejada I Characterization of muscarinic acetylcholine receptors in human penile corpus cavernosum: studies on whole tissue and cultured endothelium. J Urol 1990 Oct;144(4):1036-40 
33. Traish AM, Kim N, Wotiz HH Site-directed polyclonal antibodies inhibit binding of activated estrogen receptor to DNA. Steroids 1990 Dec;55(12):551-6 
34. Traish AM, Moran E Solubilization and sedimentation analysis of muscarinic acetylcholine receptors. J Recept Res 1991;11(6):965-83
35. Traish AM, Moran E, Saenz de Tejada I Physicochemical characterization and solubilization of endothelin receptors. Receptor 1991;1(4):229-42 
36. Vazquez-Nin GH, Echeverria OM, Fakan S, Traish AM, Wotiz HH, Martin TE. Immunoelectron microscopic localization of estrogen receptor on pre-mRNA containing constituents of rat uterine cell nuclei. Exp Cell Res 1991 Feb;192(2):396-404 
37. Bakris GL, Fairbanks R, Traish AM. Arginine vasopressin stimulates human mesangial cell production of endothelin.J Clin Invest 1991 Apr;87(4):1158-64 
38. Saenz de Tejada I, Carson MP, de las Morenas A, Goldstein I, Traish AM. Endothelin: localization, synthesis, activity, and receptor types in human penile corpus cavernosum. Am J Physiol 1991 Oct;261(4 Pt 2):H1078-85 
39. Grossman A, Traish A.M. Site-specific antibodies to the DNA-binding domain of estrogen receptor distinguish this protein from the 3H-estradiol-binding protein in pancreas. Life Sci 1992;51(11):859-67 
40. Traish AM, Moran E, Daley JT, de las Morenas A, Saenz de Tejada I. Monoclonal antibodies to human endothelin-1: characterization and utilization in radioimmunoassay and immunocytochemistry. Hybridoma 1992 Apr;11(2):147-63
41. Saenz de Tejada I, Mueller JD, de Las Morenas A, Machado M, Moreland RB, Krane RJ, Wolfe HJ, Traish AM. Endothelin in the urinary bladder. I. Synthesis of endothelin-1 by epithelia, muscle and fibroblasts suggests autocrine and paracrine cellular regulation. J Urol 1992 Oct;148(4):1290-8
42. Traish AM., Moran E, Krane RJ, Saenz de Tejada I Endothelin in the urinary bladder. II. Characterization of endothelin receptor subtypes. J Urol 1992 Oct;148(4):1299-306
43. Echeverria OM, Gonzalez Maciel A, Traish AM, Wotiz HH, Ubaldo E, Vazquez-Nin GH. Immuno-electron microscopic localization of estradiol receptor in cells of male and female reproductive and non-reproductive organs. Biol Cell 1994;81(3):257-65 
44. Quick TC, Traish AM, Niles RM Characterization of human retinoic acid receptor alpha 1 expressed in recombinant baculovirus-infected Sf9 insect cells. Receptor 1994 Summer;4(2):65-80
45. Toselli P, Moreland R, Traish AM Detection of m2 muscarinic acetylcholine receptor mRNA in human corpus cavernosum by in-situ hybridization. Life Sci 1994;55(8):621-7 
46. Traish AM, Kim N, Carson MP, de Tejada IS. Characterization of muscarinic acetylcholine receptors in cultured bovine aortic endothelial cells. J Recept Res 1994 May;14(3-4):153-66
47. Traish AM, Netsuwan N. 7 alpha-17 alpha-Dimethyl-19-nortestosterone (Mibolerone) induces conformational changes in progesterone receptors distinct from those induced by ORG 2058. Steroids 1994 Jun;59(6):362-70 
48. Traish AM, Netsuwan N, Daley J, Padman-Nathan H, Goldstein I, Saenz de Tejada I A heterogeneous population of alpha 1 adrenergic receptors mediates contraction of human corpus cavernosum smooth muscle to norepinephrine. J Urol 1995 Jan;153(1):222-7 
49. Traish AM, Gupta S, Toselli P, de Tejada IS, Goldstein I, Moreland RB. Identification of alpha 1-adrenergic receptor subtypes in human corpus cavernosum tissue and in cultured trabecular smooth muscle cells. Receptor 1995 Fall;5(3):145-57.
50. Traish AM, Palmer MS, Goldstein I, Moreland RB. Expression of functional muscarinic acetylcholine receptor subtypes in human corpus cavernosum and in cultured smooth muscle cells. Receptor 1995 Fall;5(3):159-76.
51. Moreland RB, Traish AM, McMillin MA, Smith B, Goldstein I, Saenz de Tejada I. PGE1 suppresses the induction of collagen synthesis by transforming growth factor-beta 1 in human corpus cavernosum smooth muscle. J Urol 1995 Mar;153(3 Pt 1):826-34.
52. Traish AM, al-Fadhli S, Klinge C, Kounine M, Quick TC Identification of structurally altered estrogen receptors in human breast cancer by site-directed monoclonal antibodies. Steroids 1995 Jul;60(7):467-74. 
53. Joel PB, Traish AM, Lannigan DA. Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. Mol Endocrinol 1995 Aug;9(8):1041-52. 
54. Traish AM, Newton AW, Styperek K, Beazley R, Kavanah M. Estrogen receptor functional status in human breast cancer. Diagn Mol Pathol 1995 Sep;4(3):220-8 
55. Klinge CM, Traish AM, Bambara RA, Hilf R. Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor as the receptor binds estrogen response element DNA. J Steroid Biochem Mol Biol 1996 Jan;57(1-2):51-66 
56. Edelstein RA, Zietman AL, de las Morenas A, Krane RJ, Babayan RK, Dallow KC, Traish A, Moreland RB. Implications of prostate micrometastases in pelvic lymph nodes: an archival tissue study. Urology 1996 Mar;47(3):370-5
57. Daley JT, Brown ML, Watkins T, Traish AM, Huang YH, Moreland RB, Saenz de Tejada I. Prostanoid production in rabbit corpus cavernosum: I. regulation by oxygen tension. J Urol 1996 Apr;155(4):1482-7
58. Klinge CM, Traish AM, Driscoll MD, Hilf R, Bambara RA Site-directed estrogen receptor antibodies stabilize 4-hydroxytamoxifen ligand, but not estradiol, and indicate ligand-specific differences in the recognition of estrogen response element DNA in vitro. Steroids 1996 May;61(5):278-89.
59. Traish AM, Pavao. M Binding of site-directed monoclonal antibodies to an epitope located in the A/B region (amino acids 140-154) of human estrogen receptor-induced conformational changes in an epitope in the DNA-binding domain. Steroids 1996 Sep;61(9):549-56.
60. Traish AM, Moreland RB, Huang YH, Goldstein I. Expression of functional alpha2-adrenergic receptor subtypes in human corpus cavernosum and in cultured trabecular smooth muscle cells. Recept Signal Transduct 1997;7(1):55-67. 
61. Klinge CM, Bodenner DL, Desai D, Niles RM, Traish AM. Binding of type II nuclear receptors and estrogen receptor to full and half-site estrogen response elements in vitro. Nucleic Acids Res 1997 May 15;25(10):1903-12.
62. Mulhall JP, Daller M, Traish AM, Gupta S, Park K, Salimpour P, Payton TR, Krane RJ, Goldstein I. Intracavernosal forskolin: role in management of vasculogenic impotence resistant to standard 3-agent pharmacotherapy. J Urol 1997 Nov;158(5):1752-8; discussion 1758-9. 
63. Traish AM, Huang YH, Ashba J, Pronovost M, Pavao M, McAneny DB, Moreland RB. Loss of expression of a 55 kDa nuclear protein (nmt55) in estrogen receptor-negative human breast cancer. Diagn Mol Pathol 1997 Aug;6(4):209-21. 
64. Traish AM, Moreland RB, Gallant C, Huang YH, Goldstein I. G-protein-coupled receptor agonists augment adenylyl cyclase activity induced by forskolin in human corpus cavernosum smooth muscle cells. Recept Signal Transduct 1997;7(2):121-32. 
65. Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, Sonenshein GE. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Invest 1997 Dec 15;100(12):2952-60.
66. Moreland RB, Watkins MT, Nehra A, Huang Y-H, Munarriz R, Salimpour P, Goldstein I, and Traish AM. Oxygen tension modulates TGF-beta 1 expression and PGE production in human corpus cavernosum smooth muscle cells. Molecular Urology. 2: number 1, 1998, 41-47.
67. Gupta S, Salimpour P, Saenz de Tejada I, Daley J, Gholami S, Daller M, Krane RJ, Traish AM, Goldstein I A possible mechanism for alteration of human erectile function by Digoxin: inhibition of corpus cavernosum sodium/potassium adenosine triphosphatase activity. J Urol 1998 May;159 (5):1529-36.
68. Gupta S, Moreland RB, Yang S, Gallant CM, Goldstein I, Traish AM. The expression of functional postsynaptic alpha2-adrenoceptors in the corpus cavernosum smooth muscle. Br J Pharmacol 1998 Mar;123(6):1237-45. 
69. Moreland RB, Goldstein I, Traish A. Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells. Life Sci 1998;62(20):PL 309-18. 
70. Joel PB, Traish AM, Lannigan DA. Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase. J Biol Chem 1998 May 22;273(21):13317-23. 
71. Newhall PM, Traish A, Moreland RB. Development of an organ culture experimental system to investigate collagen synthesis in corpora cavernosa. Int J Impot Res 1998 Jun;10(2):77-81.
72. Park K, Moreland RB, Goldstein I, Atala A, Traish AM. Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle. Biochem Biophys Res Commun 1998 Aug 28;249(3):612-7
73. Sadeghi-Nejad H, Moreland RB, Traish AM, Nehra A, Azadzoi KM, Goldstein I. Preliminary report on the development and characterization of rabbit clitoral smooth muscle cell culture. Int J Impot Res 1998, Sep;10(3):165-9.
74. Traish AM, Gupta S , Gallant C, Huang Y-H, and I Goldstein I. Phentolamine mesylate relaxes penile corpus cavernosum tissue by adrenergic and non-adrenergic mechanisms. Int J Impot Res 1998; Dec; 10 (4): 215-223. 
75. Ashba J, Traish AM. Estrogen and progesterone receptor concentrations and prevalence of tumor hormonal phenotypes in older breast cancer patients. Cancer Detect Prev. 1999;23:238-44.
76. Traish AM, . Kim NN, Goldstein I. and Moreland RB. Alpha adrenergic receptors in the penis: Identification, characterization and physiological function. J. Andrology 1999, 20: 671-682.
77. Moreland RB, Goldstein I, Kim NN, Traish A. Sildenafil Citrate, a Selective Phosphodiesterase Type 5 Inhibitor: Trends Endocrinol Metab. 10:97-104, 1999
78. Moreland RB, Gupta S, Goldstein I, Traish AM. Cyclic AMP modulates TGF-beta 1-induced fibrillar collagen synthesis in cultured human corpus cavernosum smooth muscle cells Int J Impot Res 10:159-163, 1998.
79. Azadzoi KM, Goldstein I, Siroky MB, Traish AM, Krane RJ, Saenz de Tejada I. Mechanisms of ischemia-induced cavernosal smooth muscle relaxation impairment in a rabbit model of vasculogenic erectile dysfunction. J Urol 160: 2216-2222, 1998.
80. Cox JD, Kim NN, Traish AM, Christianson DW. Arginase-boronic acid complex highlights a physiological role in erectile function. Nat. Struct. Biol. 6:1043-1047, 1999.
81. Moreland RB, Traish AM, McMillin MA, Smith B, Goldstein I, Saenz de Tejada I. PGE1 suppresses the induction of collagen synthesis by transforming growth factor-beta 1 in human corpus cavernosum smooth muscle. J Urol. 153:826-834, 1995. 
82. Moreland RB, Watkins MT, Nehra A, Huang Y-H, Munarriz R, Salimpour P, Goldstein I, and Traish AM. Oxygen tension modulates TGF-beta 1 expression and PGE production in human corpus cavernosum smooth muscle cells. Molecular Urology 2: 41-47, 1998.
83. Traish AM, Park K, Dhir V, Kim NN, Moreland RB, Goldstein I. Effects of castration and androgen replacement on erectile function in a rabbit model. Endocrinology 140:1861-1868, 1999. 
84. Kim. NN., Goldstein. I., Robert Moreland, RB., and Traish, AM. Alpha-adrenergic receptor blockade by phentolamine increases the efficacy of vasodilators in penile corpus cavernosum. Int J Impot Res 12: 26-36, 2000.
85. Traish, AM., Kim, NN., Huang, Y-H., Goldstein I., and. Moreland RB. Cylic AMP regulates mRNA 
    expression of alpha 1d and alpha 2a adrenergic receptors in cultured human corpus cavernosum smooth muscle cells. Int J Impot Res 12: 41-47, 2000. 
86. Kim NN, Huang Y, Moreland RB, Kwak SS, Goldstein I, Traish A. Cross-regulation of intracellular cgmp and camp in cultured human corpus cavernosum smooth muscle cells. Mol. Cell. Biol. Res. Commun. 4:10-14, 2000. 
87. Moreland RB, Albadawi H, Bratton C, Patton G, Goldstein I, Traish A, Watkins MT. O(2)-dependent prostanoid synthesis activates functional PGE receptors on corpus cavernosum smooth muscle. Am J Physiol Heart Circ Physiol. 281:H552-H558, 2001
88. McAuley IW, Kim NN, Min K, Goldstein I, Traish AM. Intracavernosal Sildenafil facilitates penile erection independent of the nitric oxide pathway. J Androl. 22:623-628, 2001. 
89. Kim NN, Cox JD, Baggio RF, Emig FA, Mistry SK, Harper SL, Speicher DW, Morris SM r, Ash DE, Traish A, Christianson DW. Probing erectile function: S-(2-boronoethyl)-L-cysteine binds to arginase as a transition state analogue and enhances smooth muscle relaxation in human penile corpus cavernosum. Biochemistry. 40:2678-2688, 2001. 
90. Kim NN, Huang YH, Goldstein I, Bischoff E, Traish, AM. Inhibition of cyclic GMP hydrolysis in human corpus cavernosum smooth muscle cells by Vardenafil, a novel, selective phosphodiesterase type 5 inhibitor. Life Sci. 69:2249-2256. 2001
91. Choi S, Min K, Kim NN, Munarriz R, Goldstein I, Traish AM. Laser oximetry: A novel noninvasive method to determine changes in penile hemodynamics in an anesthetized rabbit model. J Androl. 23:278-83, 2002. 
92. Choi S, O'Connell L, Min K, Kim NN, Munarriz R, Goldstein I, Bischoff E, Traish AM. Efficacy of  Vardenafil and Sildenafil in facilitating penile erection in an animal model. J Androl. 23:332-7, 2002. 
93. Moreland RB, Nehra A, Kim NN, Min KS, Albadawi H, Watkins MT, Goldstein I, Traish AM. Expression of functional prostaglandin D (DP) receptors in human corpus cavernosum smooth muscle. Int. J. Impot. Res. 14:446-452. 2002.
94. Traish A.M., Munarriz R., O’Connell L., Choi S., Kim S, W., Kim N.N., Huang H-Y and Goldstein I. Effects of medical and surgical castration on erectile function in an animal model. J. Andrology, 24: 381-3852003). 
95. Min K, Munarriz R, Kim NN, Choi S, O'Connell L, Goldstein I, Traish A.M. Effects of ovariectomy and estrogen replacement on basal and pelvic nerve stimulated vaginal lubrication in an animal model. J Sex Marital Ther.;29 Suppl 1:77-84, 2003.
96. Munarriz R, Hwang J, Goldstein I, Traish AM, Kim NN. Cocaine and ephedrine-induced priapism: case reports and investigation of potential adrenergic mechanisms. Urology.;62: 187-192, 2003. 
97. Munarriz R, Kim SW, Kim NN, Traish A, Goldstein I. A review of the physiology and pharmacology of peripheral (vaginal and clitoral) female genital arousal in the animal model. J Urol. 170 (2 Pt 2):S40-44; discussion S44-45, 2003.
98. Cama E, Colleluori DM, Emig FA, Shin H, Kim SW, Kim NN, Traish AM, Ash DE, Christianson DW. Human arginase II: crystal structure and physiological role in male and female sexual arousal. Biochemistry. ;42: 8445-8451, 2003. 
99. Henrich LM, Smith JA, Kitt D, Errington TM, Nguyen B, Traish AM, Lannigan DA. Extracellular signal-regulated kinase 7, a regulator of hormone-dependent estrogen receptor destruction. Mol Cell Biol. ;23: 5979-5988, 2003.
100. Zolotukhin AS, Michalowski D, Bear J, Smulevitch SV, Traish AM, Peng R, Patton J, Shatsky IN, Felber BK. PSF acts through the human immunodeficiency virus type 1 mRNA instability elements to regulate virus expression. Mol Cell Biol.;23: 6618-6630, 2003. 
101. Munarriz R, Park K, Huang YH, Saenz de Tejada I, Moreland RB, Goldstein I, Traish AM. Reperfusion of ischemic corporal tissue: physiologic and biochemical changes in an animal model of ischemic priapism. Urology;62: 760-764, 2003. 
102. Kim SW, Jeong SJ, Munarriz R, Kim NN, Goldstein I, Traish AM. Role of the nitric oxide-cyclic GMP pathway in regulation of vaginal blood flow. Int J Impot Res.;15: 355-361, 2003. 
103. Moreland RB, Kim N, Nehra A, Goldstein I, Traish A. Functional prostaglandin E (EP) receptors in human penile corpus cavernosum. Int J Impot Res.;15: 362-368, 2003. 
104. Traish AM, Kim NN, Huang YH, Min K, Munarriz R, Goldstein I. Sex steroid hormones differentially regulate nitric oxide synthase and arginase activities in the proximal and distal rabbit vagina. Int J Impot Res.;15: 397-404, 2003. 
105. Traish AM, Huang YH, Min K, Kim NN, Munarriz R, Goldstein I. Binding characteristics of [3H]D5-androstene-3 b,17 b -diol to a nuclear protein in the rabbit vagina. Steroids.; 69: 71-78, 2004.